Subscribe
Share
Share
Embed
In this week’s episode, we will examine the prognostic significance of co-mutations in IDH-mutated AML, explore an alternative method of warfarin monitoring, and finally, consider the role of tumor suppressor TP53 in determining response to venetoclax and related agents.
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.